J Korean Soc Biol Psychiatry.  2003 Nov;10(2):107-115.

Antipsychotics and Abnormality in Glucose Regulation

Affiliations
  • 1Department of Psychiatry, College of Medicine, Soonchun-hyang University Hospital, Cheonan, Korea.

Abstract


OBJECTIVE
The purpose of this study was to know about the mechanism of pathogenesis of type 2 diabetes mellitus by using of blood glucose, glucoregulatory factor, insulin resistance in schizophrenic patients receiving antipsychotics. METHOD: Modified oral glucose tolerance tests were performed in 20 schizophrenic patients receiving haloperidol, risperidone and olanzapine. Insulin, glucagon, C-peptide and cortisol were measured in 0, 15, 45, 75 minutes after glucose loading, and insulin resistance was calculated by HOMA(homeostasis model assessment) method. RESULT: Olanzapine-treated patients had significant glucose elevation 45 minutes after glucose challenge. Also modest increases in HOMA IR values were detected in patients treated with olanzapine.
CONCLUSION
Olanzapine treatment of non-diabetic patients with schizophrenia can be associated with type 2 diabetes mellitus through the elevation of glucose and insulin resistance. Elevated insulin resistance may be a causative mechanism of type 2 diabetes mellitus in patients receiving olanzapine.


MeSH Terms

Antipsychotic Agents*
Blood Glucose
C-Peptide
Diabetes Mellitus, Type 2
Glucagon
Glucose Tolerance Test
Glucose*
Haloperidol
Humans
Hydrocortisone
Insulin
Insulin Resistance
Risperidone
Schizophrenia
Antipsychotic Agents
Blood Glucose
C-Peptide
Glucagon
Glucose
Haloperidol
Hydrocortisone
Insulin
Risperidone
Full Text Links
  • JKJBP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr